An economic evaluation of investigator-led clinical trials conducted by networks

Clinical trials play a vital role in quality improvement, and the Commission wanted to understand their full potential to influence health outcomes as well as their economic impact. In 2016, the Commission engaged the Australian Clinical Trials Alliance, in partnership with Quantium Health Outcomes, to evaluate the overall health and economic impact of investigator-initiated clinical trials conducted by networks.

Governments are increasingly looking to foster greater coordination and integration between safety and quality and research activities to build self-improving models of health care. As a result, there is a growing need to determine appropriate strategies to support high-quality public-good clinical trials as an integral part of the healthcare quality, safety and value agendas in Australia.

This project is intended to support evidence-based decision-making and is closely linked to the Commission’s broader strategic priorities.

Click here to download the report and the supplementary appendix to the report.